 effect suramin human prostat cancer cell vitro suramin polyanion compound known antiparasit activ adrenocorticolyt primat clinic efficaci treatment patient metastat prostat cancer refractori convent hormon manipul activ suramin prostat cancer biolog effect drug plasma adren androgen patient human prostat adenocarcinoma cell line DU lncap-fgc cancer patient suramin approxim declin androstenedion dehydroepiandrosteron dehydroepiandrosteron sulfat level drug coloni format cell line concentr achiev human excess drug-rel toxic presenc micrograms./ml growth stimulatori effect testosteron basic fibroblast growth factor epiderm growth factor cellular concentr suramin exposur singl dose increas time cell line lncap-fgc level drug cellular level suramin androgen growth factor sensit sensit drug concentr prostat acid phosphatas prostat specif antigen lncap-fgc cell cell cultur medium presenc level suramin manner decreas cell number suramin androgen adrenocorticolyt effect capabl direct inhibitori effect cell prolifer prostat cancer cell cellular level growth stimulatori effect exogen testosteron basic fibroblast growth factor